Credit: The Lundquist Institute
Lundquist Institute investigator Dr. Virender Rehan and Advent Therapeutics awarded $3 Million NIH Small Business Innovation Research Grant for life-saving premature infant research
ADVERTISEMENT
POPULAR NEWS
-
Overlooked Dangers: Debunking Common Myths About Skin Cancer Risk in the U.S.
-
Dr. Miriam Merad Honored with French Knighthood for Groundbreaking Contributions to Science and Medicine
-
Study Reveals Beta-HPV Directly Causes Skin Cancer in Immunocompromised Individuals
-
Engineered Cellular Communication Enhances CAR-T Therapy Effectiveness Against Glioblastoma